A San Diego upstart armed with FDA clearance, first commercial shipments, and an audacious two-part pump design is stepping into a multi-billion-dollar market that the industry's giants have repeatedly fumbled
The Patient Nobody Wanted to Build For
For decades, the diabetes device…